Multimodality Treatment Including Curative Resection of Advanced NSCLC

Advanced Non-small-cell Lung Cancer Clinical Trial

Official title:

Multimodality Treatment Including Curative Resection of Advanced Stage Non-small Cell Lung Cancer - an Explorative, Retrospective Pilot Study

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04455984
• Other study ID #: 193132122
• Status: Recruiting
• Start date: May 1, 2017
• Est. completion date: August 1, 2020

Study information

• Verified date: July 2020
• Source: Medical University of Vienna
• Contact: Katharina Sinn, MD
• Phone: 004314040056440
• Email: katharina.sinn[@]meduniwien.ac.at
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

This study retrospectively evaluates clinical parameters and outcome of patients with advanced stage non-small cell lung cancer treated with neoadjuvant therapy followed by curative-intent surgery at the Divison of Thoracic Surgery at the Medical University of Vienna

Description:

This study will be undertaken as a retrospective cohort study at Devision of Thoracic Surgery, Medical University of Vienna. All patients with non-small-cell lung cancer, who received an induction chemo- or chemoradiotherapy followed by surgery in a curative intention at the Devision of Thoracic Surgery, Medical University, will be included. The aim of this study is to evaluate peri- and postoperative clinical parameters and short- and long-term outcomes in patients.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 190
• Est. completion date: August 1, 2020
• Est. primary completion date: August 1, 2020
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Patients with advanced NSCLC and multimodality treatment including curative-intent resection

Exclusion Criteria:

• Patients with early stage NSCLC

• Patients with advanced NSCLC without multimodality treatment

• Patients without curative resection

Related Conditions & MeSH terms

• Advanced Non-small-cell Lung Cancer
• Carcinoma, Non-Small-Cell Lung
• Lung Neoplasms

Intervention

Other:
• Date collection
Retrospective data analysis

Locations

Country	Name	City	State
Austria	Medical University of Vienna	Vienna

Sponsors (1)

Lead Sponsor	Collaborator
Medical University of Vienna

Country where clinical trial is conducted

Austria, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Overall survival	Overall survival of stage III NSCLC in resectable patients undergoing induction treatment and curative intent surgery; Overall survival of stage III NSCLC in resectable patients undergoing induction treatment and curative intent surgery; Overall survival of stage III NSCLC in resectable patients undergoing induction treatment and curative intent surgery Overall survival of stage III NSCLC in resectable patients undergoing induction treatment and curative intent surgery	18 years